A carregar...

FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice

Breast cancers commonly become resistant to EGFR–tyrosine kinase inhibitors (EGFR-TKIs); however, the mechanisms of this resistance remain largely unknown. We hypothesized that resistance may originate, at least in part, from molecular alterations that activate signaling downstream of EGFR. Using a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, Sun-Young, Meier, Roland, Furuta, Saori, Lenburg, Marc E., Kenny, Paraic A., Xu, Ren, Bissell, Mina J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3428077/
https://ncbi.nlm.nih.gov/pubmed/22886303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI60498
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!